Trials / Conditions / Oculocutaneous Albinism
Oculocutaneous Albinism
6 registered clinical trials studyying Oculocutaneous Albinism — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Peripheral Serotonin and Albinism NCT06138509 | Assistance Publique - Hôpitaux de Paris | — |
| Terminated | Vision Response to Dopamine Replacement NCT01663935 | University of Wisconsin, Madison | Phase 2 |
| Completed | New Strategies of Genetic Study of Patients With Oculocutaneous Albinism NCT04068961 | University Hospital, Bordeaux | — |
| Completed | Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism NCT00808106 | National Human Genome Research Institute (NHGRI) | — |
| Terminated | Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome NCT00467831 | National Human Genome Research Institute (NHGRI) | Phase 1 / Phase 2 |
| Completed | Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome NCT00001596 | William Gahl, M.D. | Phase 2 |